Publications by authors named "F Cantarutti"
Retraction notice to "Clinical characteristics of patients with mpox infection in the United Arab Emirates: a prospective cohort study" [International Journal of Infectious Diseases 134(2023) 303-306].
Int J Infect Dis
July 2024
Article Synopsis
- The study focused on how COVID-19 affected fertility intentions and pregnancy planning among residents in the UAE, highlighting a gap in research on this topic during the pandemic.
- Conducting a survey from November 2021 to June 2022, they collected data from 564 participants and found that 20.4% reported the pandemic influenced their fertility preferences, with notable differences based on age.
- The findings suggest that while some experienced issues like decreased libido post-COVID-19 infection, factors such as education and income had no significant impact on their fertility decisions, indicating a need for further research to address these challenges.
Objectives: The study aims to explore the risk factors, clinical characteristics, and outcomes of mpox infection in Abu Dhabi, United Arab Emirates (UAE).
Methods: A prospective cohort study was conducted at two communicable disease centers in Abu Dhabi, UAE and patients admitted with confirmed mpox infections between May 01, 2022 and December 31, 2022 were included in our study.
Results: A total of 176 mpox patients were admitted, of which 93% (n = 164) were men and mean age was 30.
Background: Breakthrough infections post-COVID-19 vaccination occur with the emerging variants of the SARS-CoV virus which might be either due to the newer variants escaping immune response or the waning of antibodies over time. However, there is lack of long-term follow-up evidence on the waning of immune response following inactivated COVID-19 vaccine.
Methods: A retrospective, observational study was conducted on serum samples of individuals who had received two doses of BBIBP-CorV vaccine.
COVID-19 vaccines have proven to be very safe in the clinical trials, however, there is less evidence comparing the safety of these vaccines in real-world settings. Therefore, we aim to investigate the nature and severity of the adverse effects reported and the differences based on the type of vaccine received. A survey was conducted among 1,878 adult (≥18 years) COVID-19 vaccine recipients through online survey platforms and telephonic interviews during March to September 2021.
View Article and Find Full Text PDF